Literature DB >> 2954956

Isolation and characterization of fibronectin-binding proteoglycan carrying both heparan sulfate and dermatan sulfate chains from human placenta.

M Isemura, N Sato, Y Yamaguchi, J Aikawa, H Munakata, N Hayashi, Z Yosizawa, T Nakamura, A Kubota, M Arakawa.   

Abstract

A proteoglycan was isolated from the human placenta by procedures including affinity chromatography with fibronectin immobilized on agarose. The glycosaminoglycan chains were found to be composed of heparan sulfate (86%) and dermatan sulfate (14%). The average molecular weights were estimated to be 1.8 X 10(5) for heparan sulfate and 1.2 X 10(5) for dermatan sulfate. Mouse monoclonal antibodies HS42 and HS47 were prepared against the proteoglycan, and examination of the specificity of these antibodies indicated that they recognized the core protein portion. The binding specificity, as studied by the solid phase enzyme-linked immunoassay with monoclonal antibody HS47, indicated that the proteoglycan bound to solid phase fibronectin and to laminin, but not to collagen types I, II, and IV or gelatin. Competitive immunoassays suggested that the proteoglycan bound weakly to the liquid phase-soluble fibronectin. These studies also indicated that the core protein was involved in the interaction between the proteoglycan and solid phase fibronectin. The ubiquitous distribution of this proteoglycan in the human tissues was demonstrated by the immunohistochemical method and thus suggested its important role in the tissue organization and function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954956

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Ultrastructural localization of the core protein of a basement membrane-specific chondroitin sulfate proteoglycan in adult rat skin.

Authors:  K J McCarthy; Y Horiguchi; J R Couchman; J D Fine
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Immunohistological distribution of heparan sulfate proteoglycan and chondroitin 6-sulfate in carcinomas with eccrine differentiation.

Authors:  T Kazama; M Isemura; T Nakamura; M Ito
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

3.  Immunohistochemical localization of heparan sulfate-containing proteoglycan in normal human skin with monoclonal antibodies: comparison with that of fibronectin.

Authors:  T Kazama; T Nakamura; M Isemura; Y Sato
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia.

Authors:  R D Sanderson; M Bernfield
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 5.  Proteoglycans of basement membranes.

Authors:  R Timpl
Journal:  Experientia       Date:  1993-05-15

6.  Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix.

Authors:  A D Murdoch; R V Iozzo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Selective loss of chondroitin 6-sulphate from basement membrane during progression from actinic keratosis to squamous cell carcinoma.

Authors:  T Kazama; K Fujiwara; M Ito
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Fibronectin Matrix Assembly after Spinal Cord Injury.

Authors:  Yunjiao Zhu; Cynthia Soderblom; Michelle Trojanowsky; Do-Hun Lee; Jae K Lee
Journal:  J Neurotrauma       Date:  2015-03-09       Impact factor: 5.269

9.  The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester.

Authors:  S Grässel; I R Cohen; A D Murdoch; I Eichstetter; R V Iozzo
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

Review 10.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.